Loading clinical trials...
Loading clinical trials...
The first study with rivaroxaban in pediatric subjects is a Phase I study, where the pharmacokinetic/pharmacodynamic (PK/PD) profile of rivaroxaban will be investigated to confirm that the exposure is...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bayer
Collaborators
NCT04924322 · Deep Venous Thrombosis
NCT06472518 · Iliofemoral Venous Thrombosis
NCT03986021 · Reproductive Physiological Processes, Pediatrics, and more
NCT07145645 · Musculoskeletal Injury, Pediatrics, and more
NCT07225010 · Disruptive Behavior, Pediatrics
Little Rock, Arkansas
Los Angeles, California
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions